1. Home
  2. ALDX vs OIA Comparison

ALDX vs OIA Comparison

Compare ALDX & OIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALDX
  • OIA
  • Stock Information
  • Founded
  • ALDX 2004
  • OIA 1988
  • Country
  • ALDX United States
  • OIA United States
  • Employees
  • ALDX N/A
  • OIA N/A
  • Industry
  • ALDX Biotechnology: Pharmaceutical Preparations
  • OIA Finance Companies
  • Sector
  • ALDX Health Care
  • OIA Finance
  • Exchange
  • ALDX Nasdaq
  • OIA Nasdaq
  • Market Cap
  • ALDX 160.8M
  • OIA 269.4M
  • IPO Year
  • ALDX 2014
  • OIA N/A
  • Fundamental
  • Price
  • ALDX $3.79
  • OIA $5.69
  • Analyst Decision
  • ALDX Strong Buy
  • OIA
  • Analyst Count
  • ALDX 2
  • OIA 0
  • Target Price
  • ALDX $9.50
  • OIA N/A
  • AVG Volume (30 Days)
  • ALDX 959.9K
  • OIA 97.9K
  • Earning Date
  • ALDX 07-31-2025
  • OIA 01-01-0001
  • Dividend Yield
  • ALDX N/A
  • OIA 4.88%
  • EPS Growth
  • ALDX N/A
  • OIA N/A
  • EPS
  • ALDX N/A
  • OIA N/A
  • Revenue
  • ALDX N/A
  • OIA N/A
  • Revenue This Year
  • ALDX N/A
  • OIA N/A
  • Revenue Next Year
  • ALDX N/A
  • OIA N/A
  • P/E Ratio
  • ALDX N/A
  • OIA N/A
  • Revenue Growth
  • ALDX N/A
  • OIA N/A
  • 52 Week Low
  • ALDX $1.14
  • OIA $4.93
  • 52 Week High
  • ALDX $7.20
  • OIA $6.72
  • Technical
  • Relative Strength Index (RSI)
  • ALDX 76.85
  • OIA 45.25
  • Support Level
  • ALDX $2.95
  • OIA $5.63
  • Resistance Level
  • ALDX $3.29
  • OIA $5.70
  • Average True Range (ATR)
  • ALDX 0.27
  • OIA 0.04
  • MACD
  • ALDX 0.11
  • OIA 0.00
  • Stochastic Oscillator
  • ALDX 95.89
  • OIA 55.56

About ALDX Aldeyra Therapeutics Inc.

Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.

About OIA Invesco Municipal Income Opportunities Trust

Invesco Muni Income Opps Trust operates as a diversified closed-end management investment company. Its investment objective is to provide a high level of current income which is exempt from federal income tax.

Share on Social Networks: